Home › Forums › Consumer Warnings & Recalls › Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease
Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease
You must be logged in to reply to this topic.
Members get unlimited access to Hive80. Ask questions, follow topics, join hives, and be a part of the community!
Create A New Hive Topic
FOR PEOPLE AND PETS. Food, outbreaks, products, medical devices, medicine, drugs cosmetics and more. Consumers need to stay informed to help each other and ourselves to be safer and healthier.
Auburn University Veterinary Teaching Hospital
Cedars-Sinai Medical Center
Cook your marriage happy
Houston Methodist Hospital
The Johns Hopkins Hospital
Mayo Clinic, Phoenix
Mayo Clinic, Rochester
Memorial Sloan-Kettering Cancer Center
Methodist Health System
Mount Sinai Hospital
National Suicide Prevention Lifeline
Pink Lotus Breast Center
Ronald Reagan UCLA Medical Center
Stanford Healthcare Hospital
UC Davis Veterinary Teaching Hospital
UCSF Medical Center
Your online community for health,wellness and medicine.
You must create an account to continue browsing. It’s quick, free, and members get unlimited access to Hive80. Ask questions, follow topics, join hives, make friends, and be a part of the community!
Already have an account? Login now.
Don't have an account? Click here to register now. It just takes a minute and you'll be able to start enjoying the benefits of Hive80 right away!